Perioperative risks associated with administration of andexanet alfa during emergency cardiac surgery with circulatory arrest
Perfusion · 2025
DOI: 10.1177/02676591241268395 ↗Kurz gefasst
Fallbericht in der Zeitschrift Perfusion, 2025. Verfasst von Ajami Gikandi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiac Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. Hauptthemen laut MEDLINE: Cardiac Surgical Procedures, Cardiopulmonary Bypass, Factor Xa. Die Arbeit nennt 8 Literaturangaben.
Abstract (Originalsprache)
This case report describes the perioperative course of a patient undergoing emergency repair of acute type A thoracic aortic dissection. Andexanet alfa was administered intraoperatively to obtain a dry operative field for right axillary artery exposure and cannulation. Andexanet alfa-induced heparin resistance resulted in cardiopulmonary bypass circuit and pericardial thrombosis requiring more than 400,000 units of unfractionated heparin and antithrombin III to overcome. Postoperatively, excessive chest tube output was observed secondary to protracted heparin rebound requiring continuous dosing of protamine. This case demonstrates the significant challenging perioperative, not just intraoperative, hazards associated with intraoperative andexanet alfa use during emergency cardiac surgery with cardiopulmonary bypass.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Cardiac Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
- Division of Hematology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
- Division of Anesthesiology, Perioperative and Pain Medicine, Harvard Medical School, Brigham and Women's Hospital, Boston, MA, USA.
ORCID-Profile: Ajami Gikandi
Zitieren
APA
Gikandi, A., Connors, J. M., Nabzdyk, C. G., & Zenati, M. A. (2025). Perioperative risks associated with administration of andexanet alfa during emergency cardiac surgery with circulatory arrest. Perfusion. https://doi.org/10.1177/02676591241268395
Vancouver
Gikandi A, Connors JM, Nabzdyk CG, Zenati MA. Perioperative risks associated with administration of andexanet alfa during emergency cardiac surgery with circulatory arrest. Perfusion. 2025. doi:10.1177/02676591241268395
BibTeX
@article{Gikandi2025,
author = {Gikandi, Ajami and Connors, Jean M and Nabzdyk, Christoph G and Zenati, Marco A},
title = {Perioperative risks associated with administration of andexanet alfa during emergency cardiac surgery with circulatory arrest},
journal = {Perfusion},
year = {2025},
doi = {10.1177/02676591241268395}
}
EUVIMED